Harm Reduction Radio - HAMS

Ibogaine has been long touted as a potential cure for heroin and other addictions. Premiere ibogaine researcher, Deborah C. Mash, Ph.D., Professor of Neurology and Molecular and Cellular Pharmacology at the University of Miami, talks about ibogaine safety and efficacy. Ibogaine is a substance derived from the iboga plant used in religious rituals of the Bwiti people of Africa because of its hallucinogenic properties.

Our guest this afternoon is Johann Hari, author of Chasing the Scream: The First and Last Days of the War on Drugs.

Our guest this Morning is Marc Lewis, Ph. D., author of The Biology of Desire: Why Addiction Is Not a Disease. This amazing book is chock full of the latest neuroscience, telling not only how brains get addicted to drugs but also how they recover and heal, showing that neuroplasticity is a two-edged sword. A great antidote to the drug war propaganda put forth by NIDA.

Our guest this evening is Catherine Hiller, author of Just Say Yes: a marijuana memoir. Ms. Hiller shares with us a cultural/personal history of the past fifty years of cannabis.

Our guests this evening are Ingrid Binswanger, MD, MPH, Associate Professor of Medicine at the University of Colorado School of Medicine, and Lisa Raville, Executive Director of the Harm Reduction Action Center in Denver Colorado.

Our guest today is Patty McCarthy Metcalf, executive director of Faces and Voices of Recovery. We will be discussing the meaning of recovery and ways for the harm reduction movement and the recovery movement to work together.

Our guest this evening is Meghan Ralston, harm reduction manager for the Drug Policy Alliance and author of many articles including I'm Breaking Up With the Word 'Addict' and I Hope You'll Do the Same.

Our guest today is Matthew Lebowitz of Yale University who well be discussing the negative impact of biological explanations for mental disorders on clinicians’ empathy.

Our guest this afternoon is Debra Rothschild, Ph. D., Clinical Associate Professor of Psychology at NYU and harm reduction psychotherapist in private practice in New York City.

Our guest is Sean X. Luo, M. D., Ph. D. of Columbia University who will be talking about his research on precision medicine, connectomics, and addiction and how they relate to risk and reward.